Journal Guide

Applied Clinical Research, Clinical Trials and Regulatory Affairs is an international journal with market leadership in readership and contributions that are scientific, original, relevant, innovative and statistically validated. The journal aims to further bridge the gap in the publication of clinical drug development and regulatory affairs between high growth and potentially growing regions.

Australian Prescriber is a free, independent publication providing readily accessible information about drugs and therapeutics, published by the NPS. It covers topics for health professionals, students and consumers. Read more about Australian Prescriber here.

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials.It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

An essential resource for R&D professionals and clinicians with an interest in biologic therapies.BioDrugs covers the development and use of biotechnology-based pharmaceuticals and innovative technologies for the treatment of human disease.

Biopharmaceutics & Drug Dispositionpublishes original review articles, short communications, and reports in biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those that have a direct relation to the drug discovery/development and the therapeutic use of drugs. These includes: * animal and human pharmacological studies that focus on therapeutic response. pharmacodynamics, and toxicity related to plasma and tissue concentrations of drugs and their metabolites, * in vitro and in vivo drug absorption, distribution, metabolism, transport, and excretion studies that facilitate investigations related to the use of drugs in man * studies on membrane transport and enzymes, including their regulation and the impact of pharmacogenomics on drug absorption and disposition, * simulation and modeling in drug discovery and development * theoretical treatises * includes themed issues and reviews and exclude manuscripts on * bioavailability studies reporting only on simple PK parameters such as Cmax, tmax and t1/2 without mechanistic interpretation * analytical methods Reports must contain current citation of the literature and convey new information. Biopharmaceutics & Drug Disposition is one of the top accessed and cited journals in the field, as a result of the high quality papers published in the journal, and is marketed by Wiley Blackwell across the world.

The official journal of the Japanese Breast Cancer Society, Breast Cancer publishes articles that contribute to progress in the field, in basic or translational research and also in clinical research. It develops a new focus and new perspectives for all who are concerned with breast cancer. Breast Cancer presents original articles describing clinical, epidemiological studies and laboratory investigations regarding breast cancer and related diseases. It features editorials, review articles, original articles, case reports, and short papers. The journal provides the best of up-to-date information on breast cancer, presenting readers with high-impact, original work focusing on pivotal issues.

Reports on all aspects of drug action in humansOriginal papers. reviews. editorials. letters. book reviewsNorth American. European. Australasian EditorsSpecial supplements on new drugsOpen-access after 12 monthsOnline submission through ScholarOne Manuscripts Published on behalf of the British Pharmacological Society Aims and Scope Published on behalf of the British Pharmacological Society. theBritish Journal of Clinical Pharmacologycontains papers and reports on all aspects of drug action in humans: invited review articles. original papers. short communications and correspondence. The Journal enjoys a wide readership. bridging the gap between the medical profession. clinical research and the pharmaceutical industry. Proceedings of the meetings of the Clinical Section of the British Pharmacological Society are published in abstract form. and supplements containing information on new methods. new drugs and new approaches to treatment are supplied free of charge. All editorials now available to access free online. Clickhere to access now! Readership The journal contains research and review articles on all aspects of drug action in humans. together with abstracts of clinical proceedings of the Society. The journal is recognized as one of the leading publications in its field. The readership consists of clinical pharmacologists in academic and NHS posts. pharmacologists. pharmacists. physicians as well as scientists in the pharmaceutical industry. The readership reflects the journal"s role as a bridge between the medical professions. clinical research and the pharmaceutical industry.

CPT: Pharmacometrics & Systems Pharmacology is a cross-disciplinary journal devoted to publishing advances in quantitative (e.g. modeling and simulation) methods as applied in pharmacology, physiology and therapeutics in humans. The journal welcomes original research articles in the following areas: pharmacometrics, modeling and simulation as applied to the design and evaluation of clinical trials, systems pharmacology modeling, particularly with a mechanistic link to human physiology, disease modeling, “population” or mixed-effects pharmacokinetics and pharmacodynamics modeling, physiologically-based pharmacokinetics (PBPK), model-based meta-analyses of clinical trials, pharmacokinetic-pharmacodynamic modeling, computational pharmacology, comparative efficacy, effectiveness and cost-effectiveness. Systems pharmacology may involve the application of systems biology approaches to study drug activities, targets and effects. The discipline is often defined with reference to engineering and pharmacological principles as the quantitative analysis of the dynamic interactions between drugs and a biologic system that aims to understand the behavior of the system as a whole. The common focus will be on quantitative methods that improve our understanding of pharmacology and therapeutics in humans.

Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.

Established in 1937, Cardiology provides a forum for scientific progress in the prevention, recognition, and treatment of heart disease. Bridging clinical, preclinical, and translational research, the contents include original research articles, topical reviews, and expert opinion commentaries. Sections such as “Coronary Artery Disease”, “Imaging”, “Electrophysiology and Arrhythmia”, or “eCardiology/Digital Health” highlight the wide variety of subspecialty areas covered and feature new developments in noninvasive and invasive diagnostic methods, epidemiology, as well as pharmacological, preventive, and mechanical/surgical therapies.
Cardiology publishes articles relevant to cardiologists, cardiac surgeons, internists, clinical physiologists, pharmacologists, and professionals from other areas of medicine interested in cardiovascular diseases.

Designed to objectively cover the world of cardiovascular pharmacology and therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field. Homing in on the most exciting work being done on new therapeutic agents, heart failure, hypertension and acute myocardial infarction, among others, Cardiovascular Drugs and Therapy is an authoritative source of current and relevant news that is indispensable for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Current Contents and Index Medicus, the regular articles and frequent free supplementary issues equip you with an up-to-date source defined by the need for accurate information on an ever-changing field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on extensive reviews and original articles on the treatment of cardiovascular disease. The main focus of the journal is on articles in cardiovascular pharmacology and clinical pharmacology and clinical trials of new or potential cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies and pharmacoepidemiology are also encouraged.

Chemotherapy publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacological properties of antibacterial, antiviral, and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamic properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug resistance, an increasing problem worldwide.